Aspirin: Cancer-Fighting Wonder Drug?
Aspirin has been touted as a potential heart helper, and Tuesday, the British medical journal The Lancet released some evidence that the humble analgesic might also reduce the risk of dying from various forms of cancer, and by an impressive percentage in some cases.
Aspirin has been touted as a potential heart helper, and Tuesday, the British medical journal The Lancet released some evidence that the humble analgesic might also reduce the risk of dying from various forms of cancer, and by an impressive percentage in some cases.
Gizmodo helpfully broke it down for those who don’t want to read the Lancet study:
Dig, Root, GrowGizmodo:
• After 5 years of daily aspirin, death due to gastrointestinal cancers decreased by 54% • After 20 years, death due to prostate cancer decreased by 10% • After 20 years, death due to lung cancer decreased by 30% (among those with adenocarcinomas, typically seen in nonsmokers) • After 20 years, death due to colorectal cancer decreased by 40% • After 20 years, death due to esophageal cancer decreased by 60%
This year, we’re all on shaky ground, and the need for independent journalism has never been greater. A new administration is openly attacking free press — and the stakes couldn’t be higher.
Your support is more than a donation. It helps us dig deeper into hidden truths, root out corruption and misinformation, and grow an informed, resilient community.
Independent journalism like Truthdig doesn't just report the news — it helps cultivate a better future.
Your tax-deductible gift powers fearless reporting and uncompromising analysis. Together, we can protect democracy and expose the stories that must be told.
This spring, stand with our journalists.
Dig. Root. Grow. Cultivate a better future.
Donate today.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.